Pharma Industry News

CHMP recommends Idorsia’s dual acting treatment Quviviq for insomnia patients

Quviviq can be used on a long-term basis, addressing a key limitation of existing therapiesOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]